Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Endorsement Of State Rx Discount Programs Considered

Executive Summary

The Centers for Medicare & Medicaid Services is considering Medicare endorsement for privately administered state prescription drug discount programs

You may also be interested in...



Medicare Rx Card First-Year Costs To Sponsors Would Be $13.7 Mil. – CMS

The first-year costs to a company sponsoring a Medicare-endorsed drug discount card will be about $14 mil., the Centers for Medicare & Medicaid Services estimates

Maine Medicaid Waiver Qualifies For Rx Rebates By State Contributions – Court

Maine's Medicaid waiver program qualifies for manufacturer rebates because of the state's contribution to beneficiaries' prescription costs, the D.C. federal court decided Feb. 25

Medicare Rx Discount Card Savings Estimated At $1.65 Bil. In 2003

The Centers for Medicare and Medicaid Services estimates that a Medicare drug discount card program would save seniors approximately $1.65 bil. in its first year

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039447

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel